Mitochondrial assembly receptor expression is an independent prognosticator for patients with oral tongue squamous cell carcinoma.

about

Mitochondrial assembly receptor expression is an independent prognosticator for patients with oral tongue squamous cell carcinoma.

Item

http://www.wikidata.org/entity/Q40118601

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Mitochondrial assembly recepto ...... ongue squamous cell carcinoma.

@en

type

Item

label

Mitochondrial assembly recepto ...... ongue squamous cell carcinoma.

@en

prefLabel

Mitochondrial assembly recepto ...... ongue squamous cell carcinoma.

@en

P1476

Mitochondrial assembly recepto ...... ongue squamous cell carcinoma.

@en

P2093

Chang-Han Chen

http://www.w3.org/2001/XMLSchema#string

Chih-Yen Chien

http://www.w3.org/2001/XMLSchema#string

Shau-Hsuan Li

http://www.w3.org/2001/XMLSchema#string

Wan-Ting Huang

http://www.w3.org/2001/XMLSchema#string

Wei-Che Lin

http://www.w3.org/2001/XMLSchema#string

Yan-Ye Su

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of MAS1 in breast cancer.

Angiotensin-(1-7) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor.

Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.

Metastasis of squamous cell carcinoma of the oral tongue.

Global epidemiology of oral and oropharyngeal cancer.

Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation.

SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer.

The renin-angiotensin system and cancer: old dog, new tricks.

The renin-angiotensin system as a target of novel anticancer therapy.

The renin-angiotensin system meets the hallmarks of cancer.

P304

1470320317717904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1470320317717904

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28747140

http://www.w3.org/2001/XMLSchema#string

P932

5843911

http://www.w3.org/2001/XMLSchema#string